Enanta Pharmaceuticals Inc (ENTA) Stock Analysis

Enanta Pharmaceuticals Inc (ENTA) is a publicly traded company in the HEALTHCARE sector. It trades at $12.03, carries a market capitalization of $368.42M. This page summarizes the public market data, fundamentals, and frequently asked questions for ENTA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Enanta Pharmaceuticals Inc currently has a Neutral sentiment score of 0.13.

About Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals, Inc., located in Watertown, Massachusetts, is a biotechnology firm dedicated to the discovery and development of groundbreaking small molecule therapeutics aimed at combating viral infections and liver diseases. The company boasts a robust pipeline that includes candidates specifically targeting hepatitis B and other viral pathogens, underscoring its extensive scientific expertise and innovative drug development capabilities. With a strategic focus on advancing its pro...

GNG Research Analysis

GNG Research scores Enanta Pharmaceuticals Inc (ENTA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ENTA.

Frequently Asked Questions

Does ENTA pay dividends?

Enanta Pharmaceuticals Inc (ENTA) does not currently pay a regular dividend.

What is ENTA's market cap?

Enanta Pharmaceuticals Inc (ENTA) has a market capitalization of $368.42M with a current stock price of $12.03.